Cardiovascular risks post-COVID-19 vaccination: Key findings

FHS
October 3, 2024
10:29 am

Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.

Teoxane issues competing buyout bid for Revance and its Botox rival

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 7, 2025

Researchers discover key to boosting thymus regeneration after damage

A team of international researchers led by scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in

February 3, 2025

Geneoscopy closes $105 M in Series C funding round to power next-generation of gastrointestinal diagnostic tests

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C

January 9, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.